Hope, Quality of Life, and Benefit from Treatment in Women Having Chemotherapy for Recurrent Ovarian Cancer
Lecture Presentation: 2018 Biennial Meeting
Don Dizon | USA

Chemotherapy and Targeted Therapy in Recurrent Ovarian Cancer
Lecture Presentation: 2018 Biennial Meeting
Alexander Olawaiye | USA

Clear Cell Carcinoma
Lecture Presentation: 2018 Biennial Meeting
David Tan | Singapore

Low-Grade Serous Carcinoma
Lecture Presentation: 2018 Biennial Meeting
David Gershenson | USA

Elucidating the First Line Ovarian Cancer Landscape: How Will This Affect Relapse Approach?
Lecture Presentation: 2018 Biennial Meeting
Ana Oaknin | Spain

Targeted Therapy for First Line Advanced Ovarian Cancer: Flying with Biologics
Lecture Presentation: 2018 Biennial Meeting
Robert Coleman | USA

Tailoring the Best First Line Treatment in Advanced Ovarian Cancer: Is There Still a Role for Intraperioneal or Dose-dense Chemotherapy?
Lecture Presentation: 2018 Biennial Meeting
Shannon Westin | USA

Management of HGSC
Lecture Presentation: 2018 Biennial Meeting
Fernando Maluf | Brazil

Management of Clear Cell Carcinoma – Role of Adjuvant Treatment; Management of Recurrence
Lecture Presentation: 2018 Biennial Meeting
David Tan | Singapore

Management of Low-Grade Serous Carcinoma
Lecture Presentation: 2018 Biennial Meeting
David Gershenson | USA

Topotecan (T) ± Sorafenib (S) For Platinum-Resistant Ovarian Cancer (Proc): Results Of Double-Blind Placebo-Controlled Randomized Noggo – Ago Intergroup Trial
Lecture Presentation: 2016 Biennial Meeting
Jalid Sehouli | Germany

A Randomized Placebo Controlled Phase IIb Trial Of Weekly Paclitaxel Plus/Minus Pazopanib In Persistent Or Recurrent Ovarian Cancer
Lecture Presentation: 2014 Biennial Meeting
Debra Richardson | USA

Hope, Quality of Life, and Benefit from Treatment in Women Having Chemotherapy for Recurrent Ovarian Cancer
Lecture Presentation: 2018 Biennial Meeting
Don Dizon | USA

Future Directions in the Treatment of Recurrent Ovarian Cancer
Lecture Presentation: 2018 Biennial Meeting
Noriyuki Katsumata | Japan

Elucidating the First Line Ovarian Cancer Landscape: How Will This Affect Relapse Approach?
Lecture Presentation: 2018 Biennial Meeting
Ana Oaknin | Spain

Ovarian Cancer Follow Up Strategy And Clinical Use Of Tumor Markers
Education Exchange from the 2016 Biennial Meeting
Roberto Angioli | Italy

Cell-Based Immunotherapy
Lecture Presentation: 2016 Biennial Meeting
Oliver Dorigo | USA

Checkpoint Inhibitors
Lecture Presentation: 2016 Biennial Meeting
Eric Pujade-Lauraine | France

Era of Immuno-oncology
Lecture Presentation: 2016 Biennial Meeting
Jonathan Berek | USA

Immunotherapy of Ovarian
Lecture Presentation: 2016 Biennial Meeting
Jonathan Berek | USA

Integration Of Immunotherapies
Lecture Presentation: 2016 Biennial Meeting
Kunle Odunsi | USA

Immunology Of Ovarian Cancer
Lecture Presentation: 2016 Biennial Meeting
Lana Kandalaft | Switzerland

IGCS Surgical Film Festival – Ovarian Cancer
May 8, 2020
Surgical Work Group Lead & Moderator – Vance Broach | USA
Who do we take to the OR for Primary Debulking Surgery? – Kara Long-Roche | USA
Modified Posterior Exenteration (combined TAH BSO LAR) – Luis Chiva | Spain
Right Diaphragm Resection – Reitan Ribeiro, MD | Brazil
Left Upper Quadrant & Porta Hepatis Dissection – Oliver Zivanovic | USA
MIS Interval Debulking – Jose Alejandro Rauh-Hain | USA

Clear Cell Carcinoma
Lecture Presentation: 2018 Biennial Meeting
David Tan | Singapore

Low-Grade Serous Carcinoma
Lecture Presentation: 2018 Biennial Meeting
David Gershenson | USA

Management of Clear Cell Carcinoma – Role of Adjuvant Treatment; Management of Recurrence
Lecture Presentation: 2018 Biennial Meeting
David Tan | Singapore

Upper Abdomen Surgery in Primary Ovarian Cancer Debulking
Lecture Presentation: 2018 Biennial Meeting
Dimitrios Haidopoulos |

Bulky Para-Aortic Lymph Node Resection In Advanced Stage Epithelial Ovarian Cancer
Surgical Video: 2016 Biennial Meeting
Selim Misirlioglu| Turkey

Retro-Pancreatic Lymph Node Disection, Liver Resection And Resection Of A Bulky Para-Aortic Lymph Node For Secondary Cytoreduction Of Ovarian Adenocarcinoma Using Cattell-Braasch Manoeuvre
Surgical Video: 2016 Biennial Meeting
Dogan Vatansever | Turkey

Tumor Resection from Porta Hepatis
Surgical Video: 2016 Biennial Meeting
Selim Misirlioglu| Turkey

En Bioc Resection Of Small And Large Bowel In Primary Ovarian Debulking With Bowel Obstruction
Lecture Presentation: 2014 Biennial Meeting
Christina Fotopoulou| UK

Laparoscopic Para-Aortic Lymphadenectomy
Lecture Presentation: 2014 Biennial Meeting
R. Wendel Naumann | USA

Management Of Serous Tubal Intrapepithelial Carcinoma (STIC)
Lecture Presentation: 2014 Biennial Meeting
Ginger Gardner | USA

Minimizing Complications From Bowel Surgery
Lecture Presentation: 2014 Biennial Meeting
Ian Jones | Australia

Meta-Analysis Of The Randomized EORTC And CHORUS Neoadjuvant Versus Primary Debulking Trials In Advanced Tubo-Ovarian Cancer
Education Exchange from the 2016 Biennial Meeting
Ignace Vergote |Belgium

Tumor Board – Sex cord-stromal ovarian tumors
Lecture Presentation: 2018 Biennial Meeting
Jubilee Brown | USA

Future Directions in the Treatment of Recurrent Ovarian Cancer
Lecture Presentation: 2018 Biennial Meeting
Noriyuki Katsumata | Japan

Targeted Therapy for First Line Advanced Ovarian Cancer: Flying with Biologics
Lecture Presentation: 2018 Biennial Meeting
Robert Coleman | USA

Tailoring the Best First Line Treatment in Advanced Ovarian Cancer: Is There Still a Role for Intraperioneal or Dose-dense Chemotherapy?
Lecture Presentation: 2018 Biennial Meeting
Shannon Westin | USA

Management of Low-Grade Serous Carcinoma
Lecture Presentation: 2018 Biennial Meeting
David Gershenson | USA

The Convergence of Therapeutics and Prevention: The Evolving BRCA Story
Lecture Presentation: 2016 Biennial Meeting
Karen Lu| USA